Multiplex Molecular Assay Identifies Major Vaginal Lactobacilli
By LabMedica International staff writers Posted on 26 Mar 2014 |
Image: The Qiagen Rotor-Gene Q real-time polymerase chain reaction (PCR) analyzer (Photo courtesy of General Biologicals Corporation).
Lactobacilli play a key role in promoting vaginal health and depletion of these bacteria is associated with bacterial vaginosis (BV), the most common vaginal disorder.
A novel single-tube multiplex quantitative polymerase chain reaction (qPCR) assay for the identification and quantitative assessment of the four major vaginal Lactobacillus species has been developed.
Microbiologists at the Femeris Women's Health Research Center (Hamilton, NJ, USA) assessed 60 vaginal swab specimens as part of a study on BV pathogenesis. Samples were shipped frozen in Universal Transport Medium (UTM-RT) (Copan Italia SpA; Brescia, Italy) from August to October of 2012.
DNA from clinical samples was extracted using the QIAamp Mini Kit (Qiagen; Valencia, CA, USA) in combination with pretreatment with proteinase K and mechanical homogenization. Multiplex and uniplex TaqMan qPCRs were performed using primers and probes from Integrated DNA Technologies (Coralville, IA, USA) and Qiagen’s RotorGene Q instruments were used for all qPCR assays.
The assay utility was evaluated by the analysis of lactobacilli in noncultured clinical vaginal swab specimens collected from BV patients and healthy individuals. As confirmed by the assay, L. crispatus, L. jensenii, and to a lesser extent L. gasseri, are common in the vagina of healthy women, whereas L. iners dominance is associated with BV. In order to confirm multiplex TaqMan qPCR results, bacterial cultures were isolated from vaginal samples and 11 swab specimens yielded isolates of Lactobacillus species identified in them by the multiplex TaqMan qPCR assay. A total of 11 individual Lactobacillus strains were obtained: three L. crispatus, two L. gasseri, two L. jensenii, and four L. iners. Their species assignments were confirmed by both multiplex TaqMan qPCR and uniplex SYBR Green qPCRs with 100% concordance.
The authors concludes that their assay had been validated using bacterial cultures of lactobacilli and other microbial commensal and pathogenic species populating the microflora of the lower female genital tract, human chromosomal DNA, synthetic plasmid controls, and clinical vaginal swab specimens. The multiplex qPCR assay is an advance in the detection and quantitation of the major vaginal lactobacilli, potentially facilitating the molecular diagnosis of BV and post-therapy restoration of the vaginal microflora. The study was published online on January 18, 2014, in the journal Diagnostic Microbiology and Infectious Disease.
Related Links:
Femeris Women's Health Research Center
Copan Italia
Qiagen
A novel single-tube multiplex quantitative polymerase chain reaction (qPCR) assay for the identification and quantitative assessment of the four major vaginal Lactobacillus species has been developed.
Microbiologists at the Femeris Women's Health Research Center (Hamilton, NJ, USA) assessed 60 vaginal swab specimens as part of a study on BV pathogenesis. Samples were shipped frozen in Universal Transport Medium (UTM-RT) (Copan Italia SpA; Brescia, Italy) from August to October of 2012.
DNA from clinical samples was extracted using the QIAamp Mini Kit (Qiagen; Valencia, CA, USA) in combination with pretreatment with proteinase K and mechanical homogenization. Multiplex and uniplex TaqMan qPCRs were performed using primers and probes from Integrated DNA Technologies (Coralville, IA, USA) and Qiagen’s RotorGene Q instruments were used for all qPCR assays.
The assay utility was evaluated by the analysis of lactobacilli in noncultured clinical vaginal swab specimens collected from BV patients and healthy individuals. As confirmed by the assay, L. crispatus, L. jensenii, and to a lesser extent L. gasseri, are common in the vagina of healthy women, whereas L. iners dominance is associated with BV. In order to confirm multiplex TaqMan qPCR results, bacterial cultures were isolated from vaginal samples and 11 swab specimens yielded isolates of Lactobacillus species identified in them by the multiplex TaqMan qPCR assay. A total of 11 individual Lactobacillus strains were obtained: three L. crispatus, two L. gasseri, two L. jensenii, and four L. iners. Their species assignments were confirmed by both multiplex TaqMan qPCR and uniplex SYBR Green qPCRs with 100% concordance.
The authors concludes that their assay had been validated using bacterial cultures of lactobacilli and other microbial commensal and pathogenic species populating the microflora of the lower female genital tract, human chromosomal DNA, synthetic plasmid controls, and clinical vaginal swab specimens. The multiplex qPCR assay is an advance in the detection and quantitation of the major vaginal lactobacilli, potentially facilitating the molecular diagnosis of BV and post-therapy restoration of the vaginal microflora. The study was published online on January 18, 2014, in the journal Diagnostic Microbiology and Infectious Disease.
Related Links:
Femeris Women's Health Research Center
Copan Italia
Qiagen
Latest Microbiology News
- Integrated Solution Ushers New Era of Automated Tuberculosis Testing
- Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
- Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia